Received: 13 June 2022
Accepted: 25 October 2022
First Online: 4 November 2022
: The protocol of this randomized controlled trial was approved by the Ethics Committee of Kerman University of Medical Sciences (ethics code: KMU.REC.1399.555) and registered with the Iranian Registry of Clinical Trials ExternalRef removed (identifier: IRCT20190724044318N2) on 11/02/2021. At the request of the ethics committee, the study was conducted in accordance with the Declaration of Helsinki and Ethics Publication on Committee (COPE). Other ethical criteria included written consent to enter the study and withdraw from the study whenever participants were willing. Written informed consent was obtained from each woman. Special codes were assigned to each participant to ensure information confidentiality. Lastly, the results were provided to the participants and authorities in the gynecological clinic affiliated upon their requests.
: Not applicable.
: The authors declare that they have no competing interests.